In contrast, ER+ breast cancers tend to have a higher prevalence of regulatory T cells (Tregs), natural killer (NK) cells, and neutrophils [13,35,36,37,38,39,40,41,42,43]. The gene discussed is ESR1; the disease is breast cancer.